FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020875729> ?p ?o ?g. }

• W2020875729 endingPage "275" @default.
• W2020875729 startingPage "255" @default.
• W2020875729 abstract "The efficacy and tolerability of clomipramine in the treatment of separation anxiety in dogs was tested in a prospective, randomized, double-blind, placebo-controlled, parallel-group, international multicenter clinical trial. For a diagnosis of separation anxiety, dogs had to exhibit at least one of the following signs in the absence of their owner: destruction, defecation, urination and/or vocalization, as well as the behaviour suggestive of hyper-attachment to their owner. A total of 95 dogs were randomized to receive one of the three treatments for 2-3 months: standard-dose clomipramine (1 to <2 mg/kg, PO, q. 12 h); low-dose clomipramine (0.5 to <1 mg/kg, PO, q. 12 h); and placebo (PO, q. 12 h). All dogs received behavioural therapy. Dogs were examined at four time points (days 0, 28, 56 and 84) after the initiation of therapy. Improvement in each dog's behaviour at days 28, 56 and 84 was evaluated in comparison to its behaviour at day 0.The results showed that, compared to placebo, dogs receiving standard-dose clomipramine were rated improved at least three times faster for the signs destruction, defecation and urination. At most time points, more dogs in the standard-dose clomipramine group were rated improved for the signs destruction, defecation and urination, and in an owner's global assessment of the dog's overall behaviour (p<0.05 at certain time points). However, there were no statistically significant differences at any time point between the standard dose and the placebo groups in the sign vocalization. The low-dose clomipramine group produced no statistically significant effect when compared with placebo. Mild and transient vomiting was noted as a side effect of clomipramine in a small number of dogs.It is concluded that addition of standard-dose (1 to <2 mg/kg, PO, q. 12 h) clomipramine to conventional behavioural therapy for 2-3 months ameliorated the signs of separation anxiety in dogs." @default.
• W2020875729 created "2016-06-24" @default.
• W2020875729 creator A5007033897 @default.
• W2020875729 creator A5014543634 @default.
• W2020875729 creator A5029703583 @default.
• W2020875729 creator A5034170170 @default.
• W2020875729 creator A5041184985 @default.
• W2020875729 creator A5048322825 @default.
• W2020875729 creator A5053442929 @default.
• W2020875729 creator A5063297882 @default.
• W2020875729 creator A5065645906 @default.
• W2020875729 creator A5068723574 @default.
• W2020875729 creator A5069153724 @default.
• W2020875729 creator A5070330107 @default.
• W2020875729 creator A5078296331 @default.
• W2020875729 creator A5080725113 @default.
• W2020875729 creator A5082887132 @default.
• W2020875729 creator A5086226688 @default.
• W2020875729 date "2000-04-01" @default.
• W2020875729 modified "2023-10-01" @default.
• W2020875729 title "Treatment of separation anxiety in dogs with clomipramine: results from a prospective, randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial" @default.
• W2020875729 cites W1971390079 @default.
• W2020875729 cites W1987652859 @default.
• W2020875729 cites W2010150882 @default.
• W2020875729 cites W2024056543 @default.
• W2020875729 cites W2028034162 @default.
• W2020875729 cites W2032377018 @default.
• W2020875729 cites W2034158140 @default.
• W2020875729 cites W2044048785 @default.
• W2020875729 cites W2069538391 @default.
• W2020875729 cites W2122924772 @default.
• W2020875729 cites W2123822033 @default.
• W2020875729 cites W2131823335 @default.
• W2020875729 cites W2160070901 @default.
• W2020875729 cites W4238369986 @default.
• W2020875729 cites W2016115198 @default.
• W2020875729 doi "https://doi.org/10.1016/s0168-1591(99)00127-6" @default.
• W2020875729 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10760607" @default.
• W2020875729 hasPublicationYear "2000" @default.
• W2020875729 type Work @default.
• W2020875729 sameAs 2020875729 @default.
• W2020875729 citedByCount "157" @default.
• W2020875729 countsByYear W20208757292012 @default.
• W2020875729 countsByYear W20208757292013 @default.
• W2020875729 countsByYear W20208757292014 @default.
• W2020875729 countsByYear W20208757292015 @default.
• W2020875729 countsByYear W20208757292016 @default.
• W2020875729 countsByYear W20208757292017 @default.
• W2020875729 countsByYear W20208757292018 @default.
• W2020875729 countsByYear W20208757292019 @default.
• W2020875729 countsByYear W20208757292020 @default.
• W2020875729 countsByYear W20208757292021 @default.
• W2020875729 countsByYear W20208757292022 @default.
• W2020875729 countsByYear W20208757292023 @default.
• W2020875729 crossrefType "journal-article" @default.
• W2020875729 hasAuthorship W2020875729A5007033897 @default.
• W2020875729 hasAuthorship W2020875729A5014543634 @default.
• W2020875729 hasAuthorship W2020875729A5029703583 @default.
• W2020875729 hasAuthorship W2020875729A5034170170 @default.
• W2020875729 hasAuthorship W2020875729A5041184985 @default.
• W2020875729 hasAuthorship W2020875729A5048322825 @default.
• W2020875729 hasAuthorship W2020875729A5053442929 @default.
• W2020875729 hasAuthorship W2020875729A5063297882 @default.
• W2020875729 hasAuthorship W2020875729A5065645906 @default.
• W2020875729 hasAuthorship W2020875729A5068723574 @default.
• W2020875729 hasAuthorship W2020875729A5069153724 @default.
• W2020875729 hasAuthorship W2020875729A5070330107 @default.
• W2020875729 hasAuthorship W2020875729A5078296331 @default.
• W2020875729 hasAuthorship W2020875729A5080725113 @default.
• W2020875729 hasAuthorship W2020875729A5082887132 @default.
• W2020875729 hasAuthorship W2020875729A5086226688 @default.
• W2020875729 hasConcept C108797546 @default.
• W2020875729 hasConcept C118552586 @default.
• W2020875729 hasConcept C126322002 @default.
• W2020875729 hasConcept C141071460 @default.
• W2020875729 hasConcept C142724271 @default.
• W2020875729 hasConcept C15744967 @default.
• W2020875729 hasConcept C168563851 @default.
• W2020875729 hasConcept C175768497 @default.
• W2020875729 hasConcept C197934379 @default.
• W2020875729 hasConcept C204787440 @default.
• W2020875729 hasConcept C27081682 @default.
• W2020875729 hasConcept C2778375690 @default.
• W2020875729 hasConcept C2779305415 @default.
• W2020875729 hasConcept C42219234 @default.
• W2020875729 hasConcept C558461103 @default.
• W2020875729 hasConcept C71924100 @default.
• W2020875729 hasConcept C77411442 @default.
• W2020875729 hasConceptScore W2020875729C108797546 @default.
• W2020875729 hasConceptScore W2020875729C118552586 @default.
• W2020875729 hasConceptScore W2020875729C126322002 @default.
• W2020875729 hasConceptScore W2020875729C141071460 @default.
• W2020875729 hasConceptScore W2020875729C142724271 @default.
• W2020875729 hasConceptScore W2020875729C15744967 @default.
• W2020875729 hasConceptScore W2020875729C168563851 @default.
• W2020875729 hasConceptScore W2020875729C175768497 @default.
• W2020875729 hasConceptScore W2020875729C197934379 @default.
• W2020875729 hasConceptScore W2020875729C204787440 @default.

• next